BURACCHI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 952
EU - Europa 440
AS - Asia 113
SA - Sud America 5
OC - Oceania 2
AF - Africa 1
Totale 1.513
Nazione #
US - Stati Uniti d'America 942
IT - Italia 142
IE - Irlanda 114
SE - Svezia 78
DE - Germania 60
HK - Hong Kong 53
CN - Cina 29
IN - India 17
GB - Regno Unito 16
FI - Finlandia 11
CA - Canada 10
VN - Vietnam 8
UA - Ucraina 7
AR - Argentina 4
PK - Pakistan 3
AL - Albania 2
AU - Australia 2
FR - Francia 2
RS - Serbia 2
BE - Belgio 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
NO - Norvegia 1
PH - Filippine 1
RO - Romania 1
RU - Federazione Russa 1
SC - Seychelles 1
TR - Turchia 1
Totale 1.513
Città #
Ann Arbor 397
Dublin 111
Chandler 75
Fairfield 59
New York 58
Hong Kong 53
Ashburn 41
Frankfurt am Main 41
Wilmington 35
Milan 31
Woodbridge 31
Seattle 25
Houston 20
Princeton 20
Lissone 19
Cambridge 16
Pune 15
Helsinki 11
Fremont 10
Lawrence 10
Altamura 8
Dong Ket 8
Rome 8
Shanghai 7
Dearborn 5
Garbagnate Milanese 5
Beauharnois 4
Contursi 4
Nanjing 4
Turin 4
West Jordan 4
Andover 3
Boardman 3
Bologna 3
Cerreto Guidi 3
Chicago 3
Faisalabad 3
Guangzhou 3
Hangzhou 3
Muggiò 3
Norwalk 3
San Diego 3
Somma Lombardo 3
Bahía Blanca 2
Bath 2
Berlin 2
Bonndorf 2
Brescia 2
Carate 2
Genova 2
Grafing 2
Gunzenhausen 2
Jacksonville 2
Jinan 2
Kilburn 2
London 2
Ottawa 2
Redmond 2
Rho 2
Shenyang 2
Sydney 2
Torino 2
Toronto 2
Wuhan 2
Arezzo 1
Barnet 1
Baschi 1
Boston 1
Brugherio 1
Brussels 1
Böblingen 1
Carate Brianza 1
Castelleone 1
Changsha 1
Chengdu 1
Clearwater 1
Cordovado 1
Desio 1
Edmonton 1
Falls Church 1
Gainesville 1
General Trias 1
Genoa 1
Hebei 1
Hounslow 1
Kiev 1
Kocaeli 1
Kunming 1
Leipzig 1
Los Angeles 1
Madrid 1
Magenta 1
Mahé 1
Modica 1
Monmouth Junction 1
Montréal 1
Monza 1
Nanchang 1
New Bedfont 1
Oslo 1
Totale 1.253
Nome #
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 226
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 222
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 154
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 139
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 132
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 127
Monocyte–macrophage polarization and recruitment pathways in the tumour microenvironment of B-cell acute lymphoblastic leukaemia 101
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 90
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 47
Impact of Pre-Analytical and Analytical Variables Associated with Sample Preparation on Flow Cytometric Stainings Obtained with EuroFlow Panels 42
Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts 34
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family 24
Phenotypic profiling of CD34+ cells by advanced flow cytometry improves diagnosis of Juvenile Myelomonocytic Leukemia 22
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 22
The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice 22
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia 22
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 22
Control of murine Ly6Chigh monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6 21
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia 19
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study 19
Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: Selective upregulation by rapamycin 18
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment 17
Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin 15
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 14
Increased inflammation in mice deficient for the chemokine decoy receptor D6 13
TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma 13
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study 10
Totale 1.607
Categoria #
all - tutte 6.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 5 8 11
2019/202073 8 2 2 10 7 9 7 4 6 2 4 12
2020/2021466 10 40 71 39 46 44 34 36 31 39 38 38
2021/2022257 31 39 31 19 17 23 5 10 24 19 17 22
2022/2023373 31 82 34 22 4 36 14 79 37 2 21 11
2023/2024387 13 8 17 45 55 109 91 10 25 14 0 0
Totale 1.607